Advertisement
[adinserter block="11" template="Global Header" check="exceptions" ignore="page-type"]
Home »

Idrevloride Augments Pulmonary Function in Patients With Primary Ciliary Dyskinesia

Sep 27, 2023

REFERENCES & ADDITIONAL READING

Ferkol T. Safety and efficacy of idrevloride in people with primary ciliary dyskinesia: a double-blind, randomised, placebo-controlled crossover trial (CLEANPCD). OA801, ERS 2023 Congress, 9–13 September, Milan, Italy.

MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.


EXPLORE MORE

RELEVANT ARTICLES FOR YOU

Advertisement
[adinserter block="6" template="Article Pages" check="exceptions" ignore="page-type"]